Publications

Search our bibliography using the filters on the right-hand side.

Displaying 51 through 86 of 86 publications.

Lorenzo M, Hess L, Nicol S, Parikh R, Candrilli SD, Kaye JA. Advanced soft-tissue sarcoma-related treatment patterns and outcomes in elderly patients in the United States. Poster presented at the Connective Tissue Oncology Society Annual Meeting; November 2016. Lisbon, Portugal.

Hoffman E, Mladsi DM, Cryer B, Hopkins W, Brater DC, Parikh R, Goyal R, Castellsague J, Stafkey-Mailey D, Young C. Dose-related risks of cardiovascular, gastrointestinal, and renal adverse events associated with meloxicam among patients with osteoarthritis: an observational study using US claims data. Poster presented at the 2016 ACR/ARHP Annual Meeting; November 15, 2016. Washington, DC. [abstract] Arthritis Rheumatol. 2016 Sep 28; 68(Suppl 10).

Parikh R, White C, Franzini L, Taychakhoonavudh S. Size matters, quality not so much: a hospital-level analysis of commercial prices for inpatient stays in Texas. Presented at the 6th Biennial Conference of the American Society of Health Economists; June 14, 2016. Philadelphia, PA.

Parikh RC, Du XL, Morgan RO, Lairson DR. Cost-effectiveness of treatment sequences for elderly metastatic colorectal cancer patients: a SEER-Medicare-based modeling analysis. Poster presented at the 2016 ISPOR 21st Annual International Meeting; May 24, 2016. Washington, DC. [abstract] Value Health. 2016 May; 19(3):A150.

Buck PO, Gordon LD, Meyers J, Parikh R, Kurosky S, Davis KL. Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease: a US database study. Poster presented at the National Foundation for Infectious Diseases 19th Annual Conference on Vaccine Research; April 2016. Bethesda, MD.

Parikh RC, Du XL, Morgan RO, Lairson DR. Patterns of treatment sequences in chemotherapy and targeted biologics for metastatic colorectal cancer: findings from a large community-based cohort of elderly patients. Drugs Real World Outcomes. 2016 Jan 19;1-14. doi: 10.1007/s40801-015-0059-9

Lairson DR, Parikh RC, Cormier JN, Wenyaw C, Du XL. Cost-effectiveness of chemotherapy for breast cancer and age effect in older women. Value Health. 2015 Dec;18(8):1070-8. doi: 10.1016/j.jval.2015.08.008

Du XL, Parikh RC, Lairson DR. Racial and geographic disparities in the patterns of care and costs at the end of life for patients with lung cancer in 2007–2010 after the 2006 introduction of bevacizumab. Lung Cancer. 2015 Dec;90(3):442-50.

Lairson DR, Parikh RC, Cormier JN, Wenyaw C, Du XL. Cost-utility analysis of treatments for advanced non-small cell lung cancer. Am J Pharm Benefits. 2015 Nov;7(6):271-9.

Poonawalla IB, Parikh RC, Du XL, VonVille HM, Lairson DR. Cost effectiveness of chemotherapeutic agents and targeted biologics in ovarian cancer: a systematic review. Pharmacoeconomics. 2015 Nov;33(11):1155-85. doi: 10.1007/s40273-015-0304-9

Du XL, Zhang Y, Parikh RC, Lairson DR, Cai Y. Comparative effectiveness of chemotherapy regimens in prolonging survival for two large population-based cohorts of elderly adults with breast and colon cancer in 1992–2009. J Am Geriatr Soc. 2015 Aug;63(8):1570-82.

White C, Taychakhoonavudh S, Parikh RC, Franzini L. Roles of prices, poverty, and health in medicare and private spending in Texas. Am J Manag Care. 2015 May 1;21(5):e303-11.

Franzini L, Taychakhoonavudh S, Parikh R, White C. Medicare and private spending trends from 2008 to 2012 diverse in Texas. Med Care Res Rev. 2015 Feb;72(1):96-112.

Franzini L, White C, Taychakhoonavudh S, Parikh R, Zezza M, Mikhail O. Variation in inpatient hospital prices and outpatient service quantities drive geographic differences in private spending in Texas. Health Serv Res. 2014 Dec;49(6):1944-63. doi: 10.1111/1475-6773.12192

Lairson DR, Parikh RC, Cormier JN, Wenyaw C, Du XL. Cost-utility analysis of chemotherapy regimens in elderly patients with stage III colon cancer. Pharmacoeconomics. 2014 Oct;32(10):1005-13.

Colla CH, Schpero WL, Gottlieb DJ, McClurg AB, Albert PG, Baum N, Finison K, Franzini L, Kitching G, Knudson S, Parikh RC, Symes R, Fisher ES. Tracking spending among commercially insured beneficiaries using a distributed data model. Am J Manag Care. 2014 Aug;20(8):650-7.

Parikh R, Taychakhoonavudh S, White C, Franzini L. Sources of spending variation in professional services among Texas Hospital Referral Regions: an analysis of private insurance population. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 2014. Montreal, Canada. [abstract] Value Health. 2014 May; 17(3):A18. doi: 10.1016/j.jval.2014.03.116

Lairson DR, Parikh RC, Cormier JN, Du XL. Cost-utility analysis of platinum-based chemotherapy versus taxane and other regimens for ovarian cancer. Value Health. 2014 Feb;17(1):34-42.

Stalhammar J, Stern L, Linder R, Sherman S, Parikh RC, Ariely R, Deschaseaux C, Wikstrom G. The burden of preserved ejection fraction heart failure in a real-world Swedish patient population. J Med Econ. 2014 Jan 25;17(1):43-51. doi: 10.3111/13696998.2013.848808

Murphy DR, Laxmisan A, Reis BA, Thomas EJ, Esquivel A, Forjuoh SN, Parikh RC, Khan MM, Singh H. Electronic health record-based triggers to detect potential delays in cancer diagnosis. BMJ Qual Saf. 2014 Jan;23(1):8-16. doi: 10.1136/bmjqs-2013-001874

Parikh R, Franzini L. Health care expenditure among hypertensive diabetics and its association with quality of care. Poster presented at the 141st American Public Health Association Annual Meeting; November 2013. Boston, MA.

Taychakhoonavudh S, Parikh R, Ganduglia C, Franzini L. Geographic variation in asthma admission rates across hospital referral regions in Texas: an analysis of private insurance population between 2008 and 2011. Presented at the 141st American Public Health Association Annual Meeting; November 2013. Boston, MA.

Parikh RC, Lairson DR, Cormier JN, Du XL. Cost-utility analysis of various chemotherapy regimens among elderly ovarian cancer patients: a longitudinal cohort study. Poster presented at the 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Conference; August 2013. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2013 Oct; 22(Suppl 1):172. doi: 10.1002/pds.3512

Strosberg J, Casciano R, Stern L, Parikh R, Chulikavit M, Willet J, Liu Z, Wang X, Grzegorzewski KJ. United States-based practice patterns and resource utilization in advanced neuroendocrine tumor treatment. World J Gastroenterol. 2013 Apr 21;19(15):2348-54. doi: 10.3748/wjg.v19.i15.2348

Du XL, Parikh RC, Lairson DR, Giordano SH, Cen P. Comparative effectiveness of platinum-based chemotherapy versus taxane and other regimens for ovarian cancer. Med Oncol. 2013 Mar;30(1):440. doi: 10.1007/s12032-012-0440-4

Casciano R, Wang X, Stern L, Parikh RC, Chulikavit M, Willet J, Liu Z, Strosberg J, Cadiot G, Riechelmann R. International practice patterns and resource utilization in the treatment of neuroendocrine tumors. Pancreas. 2013 Mar;42(2):339-47. doi: 10.1097/MPA.0b013e31826707cc

Parikh R, Taychakhoonavudh S, Ganduglia C, Franzini L. Geographic variation in cesarean section rates across hospital referral regions in Texas: a 2008-2010 analysis. Poster presented at the 13th Kelsey Research Foundation Health Services and Outcomes Research Annual Conference; December 2012. Houston, TX.

Mehta H, Patel J, Parikh RC, Abughosh S. Differences in obesity management among physicians. Popul Health Manag. 2012 Oct;15(5):287-92.

Stalhammar J, Stern L, Linder R, Sherman S, Parikh RC, Ariely R, Wikstrom G. Resource utilization and cost of heart failure associated with reduced ejection fraction in Swedish patients. J Med Econ. 2012 May;15(5):938-46.

Lopes M, Chulikavit M, Parikh R, Stern L, Liu Z, Rogerio J. Budget impact of everolimus in treating metastatic renal cell carcinoma. Am J Pharm Benefits. 2012;4(Special Issue):sp41-8.

Johnson ML, Parikh R, Rajan SS, Aparasu R. Effect of ACEI and ARB on health related quality of life in patients with hypertension and diabetes. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 2011. Baltimore, MD. [abstract] Value Health. 2011 May; 14(3):A46.

Mehta HB, Patel J, Parikh R, Abughosh S. Predictors of obesity treatment (counseling or pharmacotherapy) in ambulatory settings. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 2011. Baltimore, MD. [abstract] Value Health. 2011 May; 14(3):A68.

Parikh RC, Shah AJ, Rajan SS, Aparasu R, Johnson ML. Quality of care among adult patients with diabetes and hypertension. Poster presented at the 23rd Academy of Managed Care Pharmacy Conference; April 2011. Minneapolis, MN.

Parikh R, Mehta HB, Patel J, Aparasu R. Drug prescribing pattern in ambulatory care settings for chronic obstructive pulmonary disease in 2006-2007. Poster presented at the 2010 ISPOR 15th Annual International Meeting; May 2010. Atlanta, GA. [abstract] Value Health. 2010 May; 13(3):A202.

Mehta HB, Patel J, Parikh R, Aparasu R. Ten year trends in prescription of chronic obstructive pulmonary medication among adults from 1996 to 2005. Poster presented at the 2010 ISPOR 15th Annual International Meeting; May 2010. Atlanta, GA. [abstract] Value Health. 2010 May; 13(3):A204.

Mehta HB, Parikh RC, Sujit SS. Cost-effectiveness analysis of anti-obesity treatments: orlistat, sibutramine and behavioral therapy. Poster presented at the 31st Society of Medical Decision Making Conference; October 19, 2009. Los Angeles, CA.